Tranexamic Acid Tablet Availability in India
Plain tranexamic acid tablets (single-agent formulation) are widely available in India in multiple strengths including 250 mg, 500 mg, and 650 mg tablets, manufactured by numerous pharmaceutical companies—you are not limited to only the combination product with ethamsylate.
Available Single-Agent Formulations
Plain tranexamic acid tablets are marketed in India under various brand names as monotherapy products. The standard available strengths include:
- 250 mg tablets – commonly used for melasma and menorrhagia 1, 2
- 500 mg tablets – standard dosing for various indications 3
- 650 mg tablets – higher strength formulation
Common Clinical Dosing in India
The evidence demonstrates that Indian patients have been successfully treated with single-agent oral tranexamic acid across multiple studies:
- For melasma: 250 mg twice daily (total 500 mg/day) has shown clear efficacy in Indian patients over 8-12 weeks 2, 3
- For heavy menstrual bleeding: 3-4.5 g/day divided over 4-5 days during menstruation 4, 5
- For hereditary angioedema prophylaxis: 30-50 mg/kg/day in 2-3 divided doses (maximum 3-4 g daily) 6
Why You May Be Seeing Combination Products
The tranexamic acid + ethamsylate combination is heavily marketed in India for menorrhagia, but this does not mean single-agent tranexamic acid is unavailable. In fact, tranexamic acid alone is significantly more effective than ethamsylate for reducing menstrual blood loss 4, 5.
Practical Considerations
- Single-agent tranexamic acid is generally less expensive than combination products 6
- The combination with ethamsylate offers no proven additional benefit over tranexamic acid monotherapy for most indications 4
- Plain tranexamic acid tablets allow for more flexible dosing across different clinical indications (melasma, menorrhagia, hereditary angioedema) 6, 1, 4